CLDN18 and gastric cancer: While gastric cancer TCGA project reported that the CLDN18-ARHGAP26 fusion is enriched in the GS subgroup3, we found no difference in the distribution of TCGA molecular subgroup classifications between fusion-positive and fusion-negative DGCs within a larger sample set of DGCs (P = 0.7, chi-square; Fig. 4a).